Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marybeth Hans"'
Autor:
Dong-Woo Kang, Rebekah L. Wilson, Paola Gonzalo-Encabo, Mary K. Norris, Marybeth Hans, Meghan Tahbaz, Jackie Dawson, Danny Nguyen, Amber J. Normann, Alexandra G. Yunker, Nathalie Sami, Hajime Uno, Jennifer A. Ligibel, Steven D. Mittelman, Christina M. Dieli-Conwright
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundObesity is a significant contributor to breast cancer recurrence and mortality. A central mechanism by which obesity stimulates cancer progression is through chronic, low-grade inflammation in adipose tissue. Exercise interventions to targe
Externí odkaz:
https://doaj.org/article/6c162758e4e045db811de544924c90ca
Autor:
Alison, Laws, Fisher, Katlin, Marybeth, Hans, Mary, Graichen, Olga, Kantor, Christina, Minami, Brittany L, Bychkovsky, Lydia E, Pace, Rochelle, Scheib, Judy E, Garber, Tari A, King
Publikováno v:
Annals of Surgical Oncology. 30:68-77
Guidelines recommend consideration of screening MRI for patients with high-risk breast lesions (HRLs), acknowledging limited data for this moderate-risk population.This study identified patients with atypical ductal/lobular hyperplasia (ADH/ALH), lob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21fb6efbe4bcaa6c5d9b1ba5fe0f8123
https://doi.org/10.1245/s10434-022-12568-z
https://doi.org/10.1245/s10434-022-12568-z
Autor:
Alexandra Wehbe, Alison Laws, Fisher Katlin, Eshita Sharma, Marybeth Hans, Mary Graichen, Brittany Bychkovsky, Rochelle Scheib, Judy Garber, Lydia Pace, Tari King
Publikováno v:
Cancer Research. 83:P5-04
Background— There are limited data to guide breast cancer screening recommendations among females < 40 yrs of age with elevated lifetime breast cancer risk not driven by a known germline mutation. The American Cancer Society recommends initiating s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f5daf61f681050fa533a0192270ecf3
https://doi.org/10.1158/1538-7445.sabcs22-p5-04-06
https://doi.org/10.1158/1538-7445.sabcs22-p5-04-06
Autor:
Brittany Bychkovsky, Alison Laws, Fisher Katlin, Marybeth Hans, Mary Knust Graichen, Lydia E. Pace, Rochelle Scheib, Judy E. Garber, Tari A. King
Publikováno v:
Breast cancer research and treatment. 193(2)
High-risk lesions (HRLs) of the breast are an indication for chemoprevention, yet uptake is low, largely due to concerns about side effects. In 2019, low-dose (5 mg) tamoxifen was demonstrated to reduce breast cancer risk with improved tolerance. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a70263d3f3055fa6ffb688cbd71a2afd
https://pubmed.ncbi.nlm.nih.gov/35378642
https://pubmed.ncbi.nlm.nih.gov/35378642
Autor:
Alison Laws, Fisher Katlin, Marybeth Hans, Mary Graichen, Olga Kantor, Christina Minami, Brittany Bychkovsky, Lydia Pace, Rochelle Scheib, Judy Garber, Tari King
Publikováno v:
Cancer Research. 82:P3-04
Background: The value of screening MRI in women with a history of breast atypical hyperplasia (AH) or lobular carcinoma in situ (LCIS), collectively termed high-risk lesions (HRL), remains unclear. In our high-risk clinic, we recommend annual mammogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::366a737cb152c1b807ce4502b66a8dc7
https://doi.org/10.1158/1538-7445.sabcs21-p3-04-03
https://doi.org/10.1158/1538-7445.sabcs21-p3-04-03